Accedi
Accedi
Oppure accedi con
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registrati
Oppure accedi con
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Home
  2. Azioni
  3. Australia
  4. Australian Stock Exchange
  5. Creso Pharma Limited
  6. Notizie
  7. Altre lingue
    CPH   AU000000CPH2

CRESO PHARMA LIMITED

(CPH)
Tempo differito Australian Stock Exchange  -  06:10 02/12/2022
0.0210 AUD   +5.00%
30/11Creso Pharma Limited annuncia cambiamenti nel Consiglio di Amministrazione
CI
23/11Creso Pharma completa la registrazione del prodotto Anibidiolo in Corea del Sud; le azioni crollano dell'11%.
MT
22/11L'autorità di regolamentazione australiana non include più Creso Pharma nell'indagine in corso
MT
RiassuntoQuotazioniGraficiNotizieCalendarioSocietąFinanzaDerivatiFondi 
RiassuntoTutte le notizieAltre lingueComunicati stampaPubblicazioni ufficialiNotizie del settore
Notizie in altre lingue su CRESO PHARMA LIMITED
30/11Creso Pharma Limited Announces Board Changes
25/11Health House International CEO to Step Down
23/11Creso Pharma Completes Anibidiol Product Registration in South Korea; Shares Plunge 11%
22/11Australian Regulator No Longer Includes Creso Pharma to Ongoing Probe
21/11COVID-19 Resurgence in China Pushes Down Australian Shares
21/11Creso Pharma Signs Deal to Acquire Health House; Creso Shares Fall 9%
18/11Creso Pharma's Canadian Subsidiary Secures Largest Saskatchewan Order
17/11Creso Pharma Taps Co-Founder for Executive Chair Position; Shares Fall 9%
09/11Creso Pharma US Unit Enters Canada with Launch of Green Goo Products
03/11Creso Pharma Widens Reach in Canada With New Cannabis License
02/11Creso Pharma to Raise Up To $4.9 Million Via Bond Issuances
01/11Creso Pharma Logs $1 Million in Q3 Revenue
14/10Creso Pharma Limited Announces Director Appointments
13/10Creso Pharma's US Subsidiary Enters Wholesale Deal to Drive Brand Awareness, Sales Grow..
10/10Creso Pharma to Embark on Rebranding as Melodiol Global Health
10/10Creso Pharma Limited Announces Board Changes
06/10Creso Pharma Unit Completes Enrollment for Phase 2 Psychedelic Trial
05/10Creso Pharma Subsidiary Gets Canadian Research License
14/09Creso Pharma Unit Secures Ethics Approval for Phase 2 Psilocybin Trial in Canada
02/09Sierra Sage Secures USD 214,000 Purchase Order from Walmart
31/08Creso Pharma Limited Reports Earnings Results for the Half Year Ended June 30, 2022
29/08Creso Pharma Completes Sierra Sage Herbs Acquisition; Shares Down 3%
22/08Creso Pharma's Subsidiary Secures Clinical Trial Amendment Approval from Health Canada
29/07Creso Pharma Limited (ASX:CPH) signed a non-binding term sheet..
22/07Creso Pharma's Canadian Subsidiary Secures Two Purchase Orders from New Supply Program
18/07Creso Pharma's Canadian Subsidiary Seeks to Expand Scope of Upcoming Phase 2 Trial; Sha..
14/07Creso Pharma: Application for quotation of securities - CPH
12/07Creso Pharma Signs Deal to Commercialize Animal Health Products in Korea
12/07Creso Pharma Limited Signs Non-Binding, Non-Exclusive Letter of Intent with Providence ..
07/07Australian Shares Rebound Amid Increase in Payroll Jobs
07/07Creso Pharma, Gotro Global Enter Deal to Launch Sierra Sage Herbs Pet Care Products in ..
07/07Creso Pharma Limited Signs Non-Binding, Non-Exclusive Heads of Agreement with Gotro Glo..
30/06Creso Pharma Signs Deal to Launch Cannabis Range for the Taiwanese Animal Healthcare Ma..
30/06Creso Pharma Limited Secures Non-Binding, Non-Exclusive Heads of Agreement with China C..
28/06Creso Pharma's Canadian Subsidiary Launches Vaporizer Product
15/06Creso Pharma: Application for quotation of securities - CPH
30/05Creso Pharma Psychedelics Subsidiary Enters Supply Deal With Mushroom Producer
27/05Optimi Health Enters Supply Agreement with Halucenex Life Sciences
23/05Creso Pharma Signs Distribution Deal for Body Care Products in Australia; Shares Rally ..
23/05Creso Pharma Limited signed a non-binding, non-exclusive heads of agreement to acquire ..
10/05Creso Pharma Subsidiary Secures Import Permit from Health Canada
29/04Creso Pharma Records 93% Jump in Q1 Revenue
07/04Creso Pharma Acquisition Target Sierra Sage Herbs Raises US Distribution Footprint; Sha..
05/04Creso Pharma: Us roadshow - company presentation
01/04Creso Pharma: Notification of cessation of securities - CPH
01/04Creso Pharma Signs Letter of Intent for Distribution of Animal Health Products in Latin..
01/04Creso Pharma Limited Announces Commercialisation LOI Secured with Laboratorios Brouwer ..
02/03Creso Pharma: Application for quotation of securities - CPH
28/02Creso Pharma: Appendix 4E and Annual Report to Shareholders
28/02Creso Pharma Limited Reports Earnings Results for the Full Year Ended December 31, 2021
28/02Creso Pharma Subsidiary Secures PTSD Clinical Trial Authorization in Canada
28/02Creso Pharma Limited Auditor Raises 'Going Concern' Doubt
25/02Creso Pharma Raises $3.6 Million for US Expansion
25/02Creso Pharma: Proposed issue of securities - CPH
25/02Creso Pharma Limited announced that it expects to receive AUD 5 million in funding
11/02Creso Pharma Draws Closer to Developing New Hemp-Based Product
11/02Creso Pharma to Develop New Hemp-Based Lozenge Product
03/02Creso Pharma Acquiring Sierra Sage Herbs for $21 Million; Shares Up 9%
31/01Creso Pharma's Revenue More than Triples in Q4, 2021
28/01Creso Pharma: Application for quotation of securities - CPH
25/01Creso Pharma's Canadian Subsidiary Files Application for Proposed Phase 2 Psychedelic T..
24/01Creso Pharma: Initial Director's Interest Notice x3
17/01Creso Pharma: Proposed issue of securities - CPH
16/01Creso Pharma Limited Announces Appointments of William Lay as Chief Executive Officer
16/01Creso Pharma Announces Three New Board Appointments
11/01Creso Pharma's Canadian Unit to Supply Psychedelic Drug Under Special Access Program
2021Creso Pharma: Application for quotation of securities - CPH
2021Creso Pharma: Application for quotation of securities - CPH
2021Creso Pharma's Psychedelics Unit Secures Upgraded Dealer's License in Canada; Shares Up..
2021Creso Pharma: Application for quotation of securities - CPH
2021Creso Pharma: Notification of cessation of securities - CPH
2021Creso Pharma Completes Integration of ImpACTIVE Assets
2021Creso Pharma Limited Appoints Brian Walker MLC as Strategic Consultant and Chair to New..
2021Creso Pharma Enters Deal to Sell Medicinal Cannabis in Switzerland; Shares Jump 8%
2021Creso Pharma Limited to Enter Swiss Medicinal Cannabis Market
2021Creso Pharma Limited Secures Non-Binding Letter of Intent with Licensed Cannabis Grower..
2021Creso Pharma : Acquires Canadian Life Sciences Company's Assets to Strength..
2021Creso Pharma Limited completed the acquisition of Brand and Product Portfolio Assets of..
2021Creso Pharma Limited signed a letter of intent to acquire Brand and Product Portfolio A..
2021Creso Pharma : Canadian Subsidiary Concludes Testing of New Cannabis Strain..
2021Creso Pharma : Canadian Subsidiary Conducts Stability Testing for Upcoming ..
2021Creso Pharma : Canadian Subsidiary Secures Purchase Orders; Shares Rally 10..
2021Creso Pharma : Unit Enters Research Collaboration Deal With Canadian Univer..
2021Creso Pharma : Unveils New e-Commerce Channels for Deeper Reach into Europe..
2021Creso Pharma Limited Launches New E-Commerce Channels
2021Creso Pharma : Secures Two Purchase Orders from Swiss Import-Export Partner..
2021Creso Pharma Limited Secures New Purchase Orders for Human Health Products
2021Creso Pharma Limited Announces Executive Changes
2021Creso Pharma Limited Reports Earnings Results for the Half Year Ended June 30, 2021
2021Red Light Holland : Creso Pharma Agree to Terminate Merger; Falls 1.9%
2021Creso Pharma Limited cancelled the acquisition of Red Light Holland Corp. in a reverse ..
2021Creso Pharma : Canadian Subsidiary to Introduce 14 New Pot Strains
2021Creso Pharma : Halucenex Life Sciences Taps Landing Strong for Support Serv..
2021Cannabis Exec to Chair Creso Pharma, Red Light Holland's Merged Business
2021Creso Pharma : Introduces cannaDOL via Multiple Distribution Channels; Shar..
2021Creso Pharma Limited Announces to Launch Its Newly Developed, Innovative Cannadol® Gel ..
2021Creso Pharma : Completes Halucenex Life Sciences Acquisition; Shares Up 8%
2021Creso Pharma : Anibidiol Products to be Sold in Uruguay
2021Creso Pharma : Secures Hemp Lozenges, Tea Purchase Order from Red Light Hol..
2021Creso Pharma Limited Secures First Purchase Order from Sr Wholesale B.V